Bioxenix Retatrutide 60mg Prefilled Pen Kit

Bioxenix Retatrutide 60mg Prefilled Pen Kit is a prefilled research preparation containing 60mg of retatrutide in a 3ml multi-dose pen. The current product specification lists a concentration of 20mg/ml and includes six disposable pen needles.

Retatrutide is an investigational peptide-based molecule being studied for its activity across three hormone receptor pathways: GIP, GLP-1, and glucagon. This distinctive triple-agonist profile makes it an important subject in contemporary metabolic and endocrine research.

What Is Retatrutide?

Retatrutide is an experimental molecule developed to activate three metabolic hormone receptors simultaneously.

These receptors include:

• Glucose-dependent insulinotropic polypeptide (GIP)
• Glucagon-like peptide-1 (GLP-1)
• Glucagon

The combination of these three signalling pathways distinguishes retatrutide from single- and dual-receptor compounds.

Researchers are particularly interested in how simultaneous activation of these pathways influences metabolic signalling, energy regulation, glucose-related biology, and body-composition mechanisms.

Bioxenix Retatrutide Research

Bioxenix Retatrutide is presented as a research-use preparation for laboratory investigation.

Research surrounding the underlying molecule includes several areas of metabolic biology:

• GIP receptor signalling
• GLP-1 receptor signalling
• Glucagon receptor activity
• Incretin biology
• Glucose metabolism
• Energy regulation
• Endocrine signalling
• Metabolic research
• Body-composition biology

The molecule is still investigational, so scientific findings should be interpreted within the context of the available research.

Triple Receptor Research

One of the most interesting characteristics of retatrutide is its triple agonist profile.

GIP Signalling

GIP is an incretin hormone involved in nutrient-related and metabolic signalling.

Research into GIP pathways can examine relationships between nutrient sensing, endocrine communication, and glucose regulation.

GLP-1 Signalling

GLP-1 is another important incretin hormone. Research involving its receptor examines metabolic signalling, glucose-related pathways, and other physiological processes.

Glucagon Signalling

Glucagon plays an important role in energy metabolism and glucose homeostasis.

Studying glucagon receptor activity alongside GIP and GLP-1 provides researchers with a broader model for investigating metabolic regulation.

Metabolic Research Applications

The triple-pathway profile makes the compound relevant to several areas of laboratory research.

Incretin Biology

Researchers can investigate interactions between GIP and GLP-1 signalling systems.

Glucose Research

Experimental models may examine molecular mechanisms associated with glucose regulation and endocrine signalling.

Energy Metabolism

Research can explore relationships between hormone signalling and energy balance.

Endocrine Research

The molecule provides an experimental model for studying interactions between multiple metabolic hormone pathways.

Body-Composition Research

Scientists may investigate molecular pathways associated with changes in adipose tissue, energy regulation, and overall metabolic biology.

Bioxenix Retatrutide 60mg Pen Specifications

Specification	Details
Product	Retatrutide Prefilled Pen
Strength	60mg
Volume	3ml
Concentration	20mg/ml
Format	Multi-dose prefilled pen
Pen quantity	1 pen
Needles included	6 disposable pen needles
Brand	Bioxenix Pharmaceuticals
Product category	GLP-1 / Pen Kits / Peptides / Weight Loss
Intended use	Research use only

These specifications reflect the current Bioxenix product listing.

Prefilled Pen Format

Unlike a conventional lyophilised vial, this preparation is supplied in a prefilled multi-dose pen.

The current listing states that the kit contains one pen and six disposable pen needles and is supplied in a ready-to-use format without reconstitution.

For research documentation, a defined prefilled format can provide a consistent product presentation and specified concentration.

This page does not provide dosing or self-administration instructions.

Product Quality and Documentation

Researchers evaluating peptide research materials should consider the available analytical and batch documentation.

Useful documentation may include:

• Batch or lot identification
• Molecular identity
• Purity analysis
• Certificate of Analysis
• Manufacturing information
• Concentration
• Expiry information
• Storage requirements

Batch-specific documentation should be treated as the primary reference for the exact material supplied.

Storage Information

The current Bioxenix listing specifies refrigerated storage at 2–8°C, advises against freezing, and recommends protection from excessive heat and direct sunlight.

Researchers should follow the storage requirements supplied with the actual product and batch.

Appropriate storage is particularly important for prepared research materials because environmental conditions can affect product stability.

Retatrutide Research Status

Retatrutide should be distinguished from approved metabolic medicines.

As of 2026, Lilly describes the molecule as an investigational triple hormone receptor agonist targeting GIP, GLP-1, and glucagon. It remains under clinical investigation and has not received FDA approval.

Lilly reported additional Phase 3 results in July 2026 and announced plans to submit a Biologics License Application to the FDA in the first quarter of 2027.

Therefore, a research-labelled product should not be presented as an approved pharmaceutical treatment.

Retatrutide Compared With Other Metabolic Compounds

Compound	Main receptor profile
Retatrutide	GIP + GLP-1 + glucagon
Tirzepatide	GIP + GLP-1
Semaglutide	GLP-1
Cagrilintide	Amylin-related pathway

This receptor distinction is particularly important when designing metabolic research models.

Research Evidence and Limitations

Retatrutide has progressed further through clinical research than many experimental peptide compounds, but it remains investigational.

Researchers should distinguish between:

Investigational research: Laboratory and clinical studies conducted to evaluate a compound’s biological effects, safety, and potential applications.

Approved medicine: A product that has completed the relevant regulatory review and has authorised indications and manufacturing requirements.

The existence of promising clinical research does not make a research-labelled product an approved medicine.

Researchers should also evaluate the exact product, formulation, manufacturing documentation, and batch information independently.

Frequently Asked Questions

What is Bioxenix Retatrutide?

It is a Bioxenix research preparation containing retatrutide in a prefilled multi-dose pen format.

How much material is in the pen?

The current specification lists 60mg in a 3ml pen.

What is the concentration?

The listed concentration is 20mg/ml.

How many needles are included?

The current product listing specifies 6 disposable pen needles.

What receptors does retatrutide target?

The molecule is designed to activate GIP, GLP-1, and glucagon receptors.

Is retatrutide FDA-approved?

No. As of 2026, it remains investigational and is not FDA-approved.

Is this product intended for human use?

No. It is presented as a research-use product and should not be represented as an approved pharmaceutical treatment.

How should the product be stored?

The current Bioxenix listing specifies refrigerated storage at 2–8°C, with protection from freezing, excessive heat, and direct sunlight.

Research Disclaimer

Bioxenix Retatrutide 60mg Prefilled Pen Kit is supplied strictly for laboratory and scientific research. It is not intended for human or veterinary consumption or administration. Retatrutide is an investigational molecule and this research product is not an approved pharmaceutical medicine. Researchers are responsible for complying with applicable laws, regulations, institutional requirements, and laboratory safety procedures.

Bioxenix Retatrutide, Bioxenix Retatrutide, Bioxenix Retatrutide, Bioxenix Retatrutide, Bioxenix Retatrutide, Bioxenix Retatrutide,

retatrutide uk​,
reta​,
retatrutide peptide​,
reta weight loss​,
retatrutide side effects​,
reta peptide​,
retatrutide dosage​,
retatrutide dosing​,
what is reta​,
liracept​,
retatrutide how to get​,
retatrutide pen​,
buy retatrutide​.